Irishman this is an investment site . I believe investors are people who wish to make money from investing . You are correct, I sit on both sides of the fence Hence if you have read my post I use the analogy of a teeter totter . It goes up and down and I am trying to make money on each swing. This is my first time as a short term investor and thus far it has worked out well.
I am not here to blindly cheer for a company or medication, that is NOT what investments are about . People on this site cannot accept negative news about the stock, they tend to take it personally. Negative news about the stock or product is NOT negative news about them. Remaining objective to make money is the purpose. The analogy is why physicians should not treat family. You are too emotionally invested to make rational decisions. People who interpret negative news about the stock as negative news about them are too emotionally invested to be objective and that does not make a good investor.
I am trying to help people be objective to understand that even bad news can be used to make money because once again this is an investment site.
I see BP positioning themselves to take SGLT's as the premier preventative medication for CAD. KIWI made the point about revascularization which is a great scientific point. However , as I have learned and having been trying to get poepl to understand this matters not. BP will push their product and eclipse Vascepa . That's just reality. Are they ways to counter this ? Certainly. DO I think AMRN's current management has that capability - a resounding NO.
DO I hold any hope out for Vascepa ? Yes. I think the Healthnet case is the lynch pin. Currently there is no reason to educate docs to sell generics. If they get infringement protection then they can market to providers and establish a market presence increase sales and sell out to BP.
In the meantime why not make some money riding that teeter totter ?
